Bots, editor, reviewer, Administrators
13,941
edits
Feed:Trial Acronyms: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 200: | Line 200: | ||
"EPHESUS" : "Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study", | "EPHESUS" : "Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study", | ||
"LEADER" : "Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results", | "LEADER" : "Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results", | ||
"PROTECT AF" : "WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation", | |||
"MAGELLAN" : "Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin", | "MAGELLAN" : "Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin", | ||
"CAP-START" : "Community-Acquired Pneumonia—Study on the Initial Treatment with Antibiotics of Lower Respiratory Tract Infections", | "CAP-START" : "Community-Acquired Pneumonia—Study on the Initial Treatment with Antibiotics of Lower Respiratory Tract Infections", | ||
"STAR-D" : "Sequenced Treatment Alternatives to Relieve Depression", | "STAR-D" : "Sequenced Treatment Alternatives to Relieve Depression", | ||
| Line 218: | Line 218: | ||
"MATCH" : "Management of Atherothrombosis with Clopidogrel in High-risk patients", | "MATCH" : "Management of Atherothrombosis with Clopidogrel in High-risk patients", | ||
"PREDIMED" : "Prevención con Dieta Mediterránea", | "PREDIMED" : "Prevención con Dieta Mediterránea", | ||
"EAST-AFNET 4" : "The Early Treatment of Atrial Fibrillation for Stroke Prevention Trial", | |||
"PLATO" : "Platelet Inhibition and Patient Outcomes", | "PLATO" : "Platelet Inhibition and Patient Outcomes", | ||
"ORIGIN n-3 Fatty Acids" : "Investigators in the outcome Reduction with an Initial Glargine Intervention", | "ORIGIN n-3 Fatty Acids" : "Investigators in the outcome Reduction with an Initial Glargine Intervention", | ||